A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults
Christine A. Shaw, Allison August, Stephan Bart, Peta Gay Jackson Booth, Conor Knightly, Trevor Brasel, Scott C. Weaver, Hong Hong Zhou, Lori Panther
Dive into the research topics of 'A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults'. Together they form a unique fingerprint.